|
Sili, Uluhan; Leen, Ann M; Vera, Juan F et al. (2012) Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant. Cytotherapy 14:7-11
|
|
Savoldo, Barbara; Rooney, Cliona M; Di Stasi, Antonio et al. (2007) Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease. Blood 110:2620-30
|
|
Louis, Chrystal U; Paulino, Arnold C; Gottschalk, Stephen et al. (2007) A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol 29:500-5
|
|
Savoldo, Barbara; Goss, John A; Hammer, Markus M et al. (2006) Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood 108:2942-9
|
|
Gottschalk, Stephen; Rooney, Cliona M; Heslop, Helen E (2005) Post-transplant lymphoproliferative disorders. Annu Rev Med 56:29-44
|
|
Heslop, Helen E (2005) Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program :260-6
|
|
Gottschalk, Stephen; Heslop, Helen E; Rooney, Cliona M (2005) Adoptive immunotherapy for EBV-associated malignancies. Leuk Lymphoma 46:1-10
|
|
Leen, Ann M; Sili, Uluhan; Savoldo, Barbara et al. (2004) Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 103:1011-9
|
|
Heslop, H E; Gottschalk, S M; Bollard, C M et al. (2004) Options for T-cell based therapies. Vox Sang 87 Suppl 2:230-4
|
|
Bollard, Catherine M; Kuehnle, Ingrid; Leen, Ann et al. (2004) Adoptive immunotherapy for posttransplantation viral infections. Biol Blood Marrow Transplant 10:143-55
|
Showing the most recent 10 out of 42 publications
